— Know what they know.
Not Investment Advice

MLAB NASDAQ

Mesa Laboratories, Inc.
1W: -1.1% 1M: +1.4% 3M: +29.2% YTD: +67.2% 1Y: +88.5% 3Y: +25.8% 5Y: -57.6%
$132.55
+3.25 (+2.51%)
 
Weekly Expected Move ±5.0%
$119 $126 $133 $139 $146
NASDAQ · Healthcare · Medical - Specialties · Tech Score Buy · Power 63 · $741.7M mcap · 5M float · 3.73% daily turnover · Short 44% of daily vol

Balance Sheet Trends

Total Assets
$428M -1.3% ▼
5Y CAGR: -6.6%
Total Liabilities
$242M -11.7% ▼
5Y CAGR: +4.3%
Shareholders Equity
$186M +16.5% ▲
5Y CAGR: -14.4%
Cash & Investments
$27M -1.4% ▼
5Y CAGR: -36.6%
Total Debt
$169M -7.0% ▼
5Y CAGR: +2.9%
Net Debt
$142M -7.9% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2022FY2023FY2024FY2025FY2026
— Assets —
Cash$49M$33M$28M$27M$27M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$49M$33M$28M$27M$27M
Net Receivables$41M$43M$39M$42M$44M
Inventory$25M$35M$33M$25M$26M
Other Current Assets$0$4M$3M$3M$4M
Total Current Assets$124M$119M$109M$103M$106M
Property, Plant & Equip.$29M$28M$41M$32M$48M
Goodwill & Intangibles$541M$503M$294M$279M$270M
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$12M$10M$867K$18M$2M
Total Non-Current Assets$583M$543M$337M$331M$321M
Total Assets$707M$662M$447M$433M$428M
— Liabilities —
Accounts Payable$8M$6M$6M$6M$5M
Short-Term Debt$0$0$0$101M$6M
Deferred Revenue$15M$16M$15M$15M$15M
Other Current Liabilities$0$0$15M$0$12M
Total Current Liabilities$48M$43M$44M$164M$62M
Long-Term Debt$218M$183M$222M$77M$146M
Other Non-Current Liab.$8M$8M$9M$12M$0
Total Non-Current Liabilities$266M$225M$257M$110M$180M
Total Liabilities$314M$268M$301M$274M$242M
— Equity —
Common Stock$313M$332M$344M$359M$375M
Retained Earnings$77M$74M-$183M-$189M-$186M
Accumulated OCI$4M-$13M-$15M-$10M-$3M
Total Stockholders Equity$394M$393M$145M$160M$186M
Total Liabilities & Equity$707M$662M$447M$433M$428M
— Key Metrics —
Total Debt$221M$186M$231M$181M$169M
Net Debt$172M$153M$203M$154M$142M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms